[New Drug Journey] Tried and Tested
31/05/2024
Professor Leung Wai-Keung, the Chief Director of The University of Hong Kong Clinical Trials Centre (HKU-CTC) has shared insights in the latest HKU Bulletin issued in May 2024 on how HKU-CTC plays the role as a regional leader in the industry.
About one-quarter of drugs approved by the US Food and Drug Administration (FDA) are tested at HKU-CTC and Mainland firms are increasingly using its services. We are now preparing for higher growth in the face of new opportunities and stiffer competition.
Clinical Trial Column Article: 'Promote Scientific Research, Protect Public Health: Hong Kong Serving as A Hub for Clinical Trials Development Opportunities'
02/05/2024
Clinical Trial Column Article: 'Promote Scientific Research, Protect Public Health: Hong Kong Serving as A Hub for Clinical Trials Development Opportunities'
02/05/2024
Clinical Trial Column Article: 'Postmarketing Surveillance Trial Supports the Public to Make Informed Choices'
26/04/2024
Clinical Trial Column Article: 'Postmarketing Surveillance Trial Supports the Public to Make Informed Choices'
26/04/2024
[Trial Results Release] Ideal Findings Reflected from the Phase 1 Study on Biological Therapy for Severe Asthma Patients
22/04/2024
[Trial Results Release] Ideal Findings Reflected from the Phase 1 Study on Biological Therapy for Severe Asthma Patients
22/04/2024
Sincere gratitude to all the volunteers participating in the study related to biological therapies targeting eosinophilic asthma earlier in 2019 (CTC1843), leading by the University of Hong Kong Clinical Trials Centre (HKU-CTC). We are thrilled to announce that the research data of the Phase III Study has already been submitted to the National Medical Products Administration (NMPA) for evaluation. This will certainly bring hopes to severe asthma patients if approval is granted by the NMPA eventually!
Clinical Trial Column Article: 'Clinical Trial: New Hopes for Cancer Treatment'
15/04/2024
[Centre Activity] HKU Clinical Trials Centre Silver Jubilee Ceremony & Gala Dinner 2023
28/03/2024
[Centre Activity] HKU Clinical Trials Centre Silver Jubilee Ceremony & Gala Dinner 2023
28/03/2024
HKU-CTC has been walking together with Hong Kong in the past 25 years in advancing human healthcare. To commemorate this milestone, we held the silver jubilee celebration event earlier. The event brought together government officials, academic and industry representatives, as well as our dedicated colleagues in clinical research, with some 300 attendees. It was a joyous occasion started with speeches from Professor Richard Wong, Acting President & Vice-Chancellor of HKU, Dr. Stephen Wong, Head of Chief Executive’s Unit of HKSAR Government, Mr. Henry Fan, Chairman of Hospital Authority and Professor Leung Wai-Keung, HKU-CTC’s Chief Director, who commended the center's contributions to healthcare innovation in Hong Kong and its commitment to societal well-being. We also took the opportunity to express our appreciation to 10 colleagues who have been of service with HKU-CTC for 5 to 20 years, and congratulate our 5 trainees for their successful completion of our trainee programme during 2022-23. Let's take a moment to relive the highlights of this memorable evening!
Clinical Trial Column Article: 'Phase I Clinical Trials: From Experimentation to Clinical Practice'
27/03/2024
.png)
Clinical Trial Column Article: 'Phase I Clinical Trials: From Experimentation to Clinical Practice'
27/03/2024
Clinical trial column articles will be featured in am730 for six consecutive weeks!
20/03/2024
.png)
Clinical trial column articles will be featured in am730 for six consecutive weeks!
20/03/2024